A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

Clinical trial NCT04711603 · COMPLETED

Trial details

NCT number: NCT04711603
Sponsor: Kissei Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Uremic Pruritus

Start date: 2021-01-16
Primary completion: 2022-01-25
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.